Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccinationArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome addition adenoviral-vectored vaccine antibody AZD1222 binding antibody BNT162b2 booster booster vaccination Booster vaccine comparable Complete coronavirus Coronavirus 2019 COVID-19 demonstrated develop dose Effect enrolled enzyme-linked immunosorbent Heterologous highest immune evasion immune response immunogenicity analysis individual induce interferon-γ Messenger RNA Mild moderate mRNA mRNA vaccine mRNA-1273 mutations NAb titer NAbs neutralization neutralize Neutralizing Neutralizing activity neutralizing antibody observé omicron Omicron variant overcome participant raise receive receiving reduction response Serious Adverse Events significant increase Spike protein T-cell activation T-cell Response T-cell responses vaccination Vaccine waning immunity was recorded were measured [DOI] 10.1002/jmv.28044 PMC 바로가기
Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRVSARS-CoV-2 단백질 소단위 백신 ZF2001 및 mRNA 백신 RRV의 타고난 면역 특징의 전사체 분석Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 유전자 메커니즘, 진단, [키워드] Activation Analysis Anti-viral antibody approach binding CD74 Cell comparable COVID-19 cytokine Cytokines early response elicited expression level expression of gene framework Gene Expression Genes immune response immune responses immunization innate immune innate immune response Innate immunity involved mapped MHC class mRNA mRNA vaccine neutralization Neutralization antibody Pattern recognition pattern recognition receptor Pattern recognition receptors post vaccination Protein subunit protein subunit vaccine PRRs RNA degradation robust SARS-CoV-2 SARS-CoV-2 protein subunit Subunit vaccine Tap1 titre titres Transcription transcriptional Transcriptome transcriptome sequencing transcriptomic transduction Vaccine ZF2001 [DOI] 10.1080/22221751.2022.2059404 PMC 바로가기 [Article Type] Article
Vitamin D deficiency in critically ill COVID-19 ARDS patientsArticle Published on 2022-12-012023-07-06 Journal: Clinical nutrition (Edinburgh, Scotland) [Category] COVID19(2023년), [키워드] acute respiratory distress syndrome Critical care immune response nutrient supplementation Vitamin D [DOI] 10.1016/j.clnu.2021.03.001 PMC 바로가기
Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19)Review Published on 2022-12-012023-07-10 Journal: Inflammopharmacology [Category] COVID19(2023년), [키워드] COVID-19 immune response Lycopene oxidative stress pro-inflammatory cytokine [DOI] 10.1007/s10787-022-01061-4 PMC 바로가기 [Article Type] Review
Ultrarapid and ultrasensitive detection of SARS-CoV-2 antibodies in COVID-19 patients via a 3D-printed nanomaterial-based biosensing platformArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] 3D biosensor 3D printing Additive manufacturing antibody Antibody detection coated with Concentration COVID-19 COVID-19 antibodies COVID-19 patient COVID-19 patients Critical detected antibody disease domain Efficacy Epidemics Epidemiology evaluate Gold nanoparticle Graphene oxide human plasma samples immune response Immunity Infection Interaction manuscript nucleocapsid Outbreaks Patient patients without COVID-19 platform Quantitative Rapid rapid antibody detection. rapid antibody test RBD reported SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antigens serological Spike protein the antibodies the N protein vaccination Vaccine Viral protein were used [DOI] 10.1002/jmv.28075 PMC 바로가기
Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIVArticle Published on 2022-12-012023-07-10 Journal: The Journal of Infection [Category] COVID19(2023년), [키워드] Antibody responses Breakthrough infection cellular COVID-19 vaccine HIV humoral immune response neutralisation omicron people living with HIV SARS-CoV-2 mRNA vaccine third dose [DOI] 10.1016/j.jinf.2022.09.006 PMC 바로가기
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccinationArticle Published on 2022-12-012022-11-15 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome antibody Antibody titers coronavirus coronavirus disease Course COVID-19 Efficacy examined first vaccination immune response Infection Neutralizing activity Neutralizing titer onset of disease Patient SARS-CoV-2 shown single dose vaccination [DOI] 10.1016/j.jiac.2022.08.026 PMC 바로가기
The differential immune response in mild versus fatal SARS-CoV2 infectionArticle Published on 2022-12-012023-07-10 Journal: Annals of diagnostic pathology [Category] COVID19(2023년), [키워드] COVID-19 fatal disease immune response Mild disease SARS-CoV2 [DOI] 10.1016/j.anndiagpath.2022.152032 PMC 바로가기
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIVHIV 보균자에서 비활성화된 SARS-CoV-2 백신의 안전성 및 면역원성Observational Study Published on 2022-12-012022-09-12 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] adverse event age Analysis binding domain booster dose CD4 CD4 count CD4 counts Cell COVID-19 declined Efficacy enrolled evaluated Factor Frequency Gender geometric GMT healthy control healthy controls HIV humoral humoral immune response IgG immune immune response Immunocompromised in both groups inactivated Inactivated vaccine less MBC memory B occurred Patient PLWH predicted prospective observational study reduced remained reported response responses robust Safety SARS-CoV-2 SARS-CoV-2 vaccine Serious Adverse Event Seven significantly vaccination Viral load with HIV [DOI] 10.1080/22221751.2022.2059401 PMC 바로가기 [Article Type] Observational Study
Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccinesCOVID-19 백신 접종 후 면역 장수: 현재 승인된 백신에 대한 종합 검토Review Published on 2022-11-302022-09-12 Journal: Human vaccines & immunotherapeutics [Category] MERS, 진단, [키워드] Ad26.COV2.S anti-Spike IgG antibody antibody persistence approved Asymptomatic AZD1222 BNT162b1 BNT162b2 BNT162b2 vaccine BNT162b2 vaccines booster dose Cell-mediated immunity COVID-19 COVID-19 vaccination detectable first dose Humoral immunity IgA antibodies immune response Immunity immunogenicity induce long-term immunity Long-term protection Longevity mRNA-1273 mRNA-1273 vaccine neutralizing effect peaked persistence Perspective produced provide SARS-CoV-2 Spread systematic review T-cell T-cell immunity T-cell Response Vaccine Vaccines [DOI] 10.1080/21645515.2022.2037384 PMC 바로가기 [Article Type] Review